[Featured Stock] Esbiomedics Surges on Parkinson's Treatment Hopes↑

S-Biomedics is showing strong performance.

As of 9:27 AM on the 22nd, S-Biomedics is trading at 47,400 KRW on the KOSDAQ market, up 8,400 KRW (21.54%) compared to the previous trading day.

S-Biomedics, a developer of embryonic stem cell therapies, recently announced the development of a new drug that fundamentally treats Parkinson's disease using its platform technology.

This content was produced with the assistance of AI translation services.